Provided by Tiger Trade Technology Pte. Ltd.

Candel Therapeutics, Inc.

5.04
-0.1300-2.51%
Volume:1.02M
Turnover:5.18M
Market Cap:369.15M
PE:-6.99
High:5.22
Open:5.22
Low:5.02
Close:5.17
52wk High:8.97
52wk Low:4.25
Shares:73.24M
Float Shares:45.48M
Volume Ratio:0.71
T/O Rate:2.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7210
EPS(LYR):-0.7210
ROE:-64.58%
ROA:-25.95%
PB:7.11
PE(LYR):-6.99

Loading ...

Aug 05, 2022

Major Issues Report

8-K - Current report
Aug 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2022

Major Issues Report

8-K - Current report
Jun 06, 2022

Major Issues Report

8-K - Current report
May 27, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2022

Major Issues Report

8-K - Current report
Mar 29, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 29, 2022

Major Issues Report

8-K - Current report
Mar 29, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Major Issues Report

8-K - Current report
Jan 31, 2022

Major Issues Report

8-K - Current report
Aug 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 30, 2021

Major Issues Report

8-K - Current report